Elaine Ryan

1.4k total citations · 1 hit paper
17 papers, 1.1k citations indexed

About

Elaine Ryan is a scholar working on Organic Chemistry, Endocrine and Autonomic Systems and Molecular Biology. According to data from OpenAlex, Elaine Ryan has authored 17 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Organic Chemistry, 8 papers in Endocrine and Autonomic Systems and 6 papers in Molecular Biology. Recurrent topics in Elaine Ryan's work include Circadian rhythm and melatonin (8 papers), Free Radicals and Antioxidants (6 papers) and Organic Chemistry Cycloaddition Reactions (3 papers). Elaine Ryan is often cited by papers focused on Circadian rhythm and melatonin (8 papers), Free Radicals and Antioxidants (6 papers) and Organic Chemistry Cycloaddition Reactions (3 papers). Elaine Ryan collaborates with scholars based in United States. Elaine Ryan's co-authors include Cen Xu, Frank D. Yocca, Thaddeus F. Molski, Kevin D. Burris, Tetsuro Kikuchi, Perry B. Molinoff, Katsura Tottori, Cathy D. Mahle, Lawrence G. Iben and Li‐Qiang Sun and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and Life Sciences.

In The Last Decade

Elaine Ryan

17 papers receiving 1.0k citations

Hit Papers

Aripiprazole, a Novel Antipsychotic, Is a High-Affinity P... 2002 2026 2010 2018 2002 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors
    2002 736 citations Kevin D. Burris, Thaddeus F. Molski et al. Journal of Pharmacology and Experimental Therapeutics profile →

Peers

Elaine Ryan
Richard D. Hartman United States
Cen Xu United States
Stevin H. Zorn United States
P A Seymour United States
R J Baldessarini United States
Anton A. H. P. Megens Belgium
Mitsutaka Nakamura Japan
Penny G. Threlkeld United States
Kimberly E. Vanover United States
H Rosengarten United States
Richard D. Hartman United States
Elaine Ryan
Citations per year, relative to Elaine Ryan Elaine Ryan (= 1×) peers Richard D. Hartman

Countries citing papers authored by Elaine Ryan

Since Specialization
Citations

This map shows the geographic impact of Elaine Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elaine Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elaine Ryan more than expected).

Fields of papers citing papers by Elaine Ryan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elaine Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elaine Ryan. The network helps show where Elaine Ryan may publish in the future.

Co-authorship network of co-authors of Elaine Ryan

This figure shows the co-authorship network connecting the top 25 collaborators of Elaine Ryan. A scholar is included among the top collaborators of Elaine Ryan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Elaine Ryan. Elaine Ryan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
Sun, Li‐Qiang, Jie Chen, Stephen R. Bertenshaw, et al.. (2005). (R)-2-(4-Phenylbutyl)dihydrobenzofuran derivatives as melatoninergic agents. Bioorganic & Medicinal Chemistry Letters. 15(5). 1345–1349. 18 indexed citations
2.
Sun, Li‐Qiang, Jie Chen, Stephen R. Bertenshaw, et al.. (2005). (R)‐2‐(4‐Phenylbutyl)dihydrobenzofuran Derivatives as Melatoninergic Agents.. ChemInform. 36(29). 1 indexed citations
3.
Sun, Li‐Qiang, Jie Chen, Graham Johnson, et al.. (2004). Design and synthesis of benzoxazole derivatives as novel melatoninergic ligands. Bioorganic & Medicinal Chemistry Letters. 14(5). 1197–1200. 56 indexed citations
4.
Deskus, Jeffrey A., et al.. (2004). 4-Substituted anilides as selective melatonin MT2 receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(4). 1023–1026. 13 indexed citations
5.
Sun, Li‐Qiang, Jie Chen, Marc A. Bruce, et al.. (2004). Synthesis and structure–activity relationship of novel benzoxazole derivatives as melatonin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 14(14). 3799–3802. 76 indexed citations
6.
Sun, Li‐Qiang, Jie Chen, Lawrence G. Iben, et al.. (2004). N-{2-[2-(4-Phenylbutyl)benzofuran-4-yl]cyclopropylmethyl}acetamide: an orally bioavailable melatonin receptor agonist. Bioorganic & Medicinal Chemistry Letters. 14(20). 5157–5160. 17 indexed citations
7.
Deskus, Jeffrey A., et al.. (2004). 4‐Substituted Anilides as Selective Melatonin MT2 Receptor Agonists.. ChemInform. 35(23). 1 indexed citations
8.
Mattson, Ronald J., John D. Catt, C.P. Sloan, et al.. (2003). Indanyl piperazines as melatonergic MT2 selective agents. Bioorganic & Medicinal Chemistry Letters. 13(6). 1199–1202. 26 indexed citations
9.
Sun, Li‐Qiang, Jie Chen, Ronald J. Mattson, et al.. (2003). Heterocyclic aminopyrrolidine derivatives as melatoninergic agents. Bioorganic & Medicinal Chemistry Letters. 13(24). 4381–4384. 11 indexed citations
10.
Burris, Kevin D., Thaddeus F. Molski, Cen Xu, et al.. (2002). Aripiprazole, a Novel Antipsychotic, Is a High-Affinity Partial Agonist at Human Dopamine D2 Receptors. Journal of Pharmacology and Experimental Therapeutics. 302(1). 381–389. 736 indexed citations breakdown →
11.
Sit, Sing‐Yuen, Kai Xie, Matthew T. Taber, et al.. (2002). (+)-Dinapsoline:  An Efficient Synthesis and Pharmacological Profile of a Novel Dopamine Agonist. Journal of Medicinal Chemistry. 45(17). 3660–3668. 13 indexed citations
12.
Mahle, Cathy D., et al.. (1997). Melatonin Modulates Vascular Smooth Muscle Tone. Journal of Biological Rhythms. 12(6). 690–696. 63 indexed citations
13.
Yocca, Frank D., Arlene S. Eison, Deborah K. Hyslop, et al.. (1991). Unique modulation of central 5-HT2 receptor binding sites and 5-HT2 receptor-mediated behavior by continuous gepirone treatment. Life Sciences. 49(24). 1777–1785. 22 indexed citations
14.
Banovac, Krešimir, Elaine Ryan, & Mary Jo O’Sullivan. (1986). Triiodothyronine (T3) nuclear binding sites in human placenta and decidua. Placenta. 7(6). 543–549. 19 indexed citations
15.
BENNETT, G. B., et al.. (1981). A potent, new, sedative-hypnotic agent: 5,7-dihydro-5,5,7,7-tetramethyl-3-(3-nitrophenyl)furo[3,4-e]-as-triazine 4-oxide. Journal of Medicinal Chemistry. 24(5). 490–496. 10 indexed citations
16.
Simpson, Richard J., et al.. (1975). ChemInform Abstract: NOVEL TRICYCLIC SYSTEMS, OXAZOLE, THIAZOLE, AND IMIDAZOLE ANALOGS OF THE AMITRIPTYLINE TYPE. Chemischer Informationsdienst. 6(15). 2 indexed citations
17.
Iorio, Louis C., et al.. (1975). Blockade by narcotic drugs of naloxone-precipitated jumping in morphine-dependent mice.. Journal of Pharmacology and Experimental Therapeutics. 192(1). 58–63. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard D. Hartman Breakdown of academic impact, for papers by Cen Xu Breakdown of academic impact, for papers by Stevin H. Zorn Breakdown of academic impact, for papers by P A Seymour Breakdown of academic impact, for papers by R J Baldessarini Breakdown of academic impact, for papers by Anton A. H. P. Megens Breakdown of academic impact, for papers by Mitsutaka Nakamura Breakdown of academic impact, for papers by Penny G. Threlkeld Breakdown of academic impact, for papers by Kimberly E. Vanover Breakdown of academic impact, for papers by H Rosengarten
Rankless by CCL
2026